ACLS
Axcelis Technologies, Inc.
ACLS has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over ACLS overall, supported by stronger fundamentals and stronger valuation.
ACLS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
ACLS's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
ACLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $48.20 | -55% |
| Forward | 18x | $108 | — |
| Fair | 22x | $73.95 | -32% |
| Current | 32x | $108 | — |
| Expensive | 34x | $113 | +4.9% |
Historical ranges are pointers, not guarantees.
ACLS's PE is in its expensive range at 32x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over ACLS in the historical PE scenario, which offers more potential upside but is not a forecast.
ACLS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for ACLS, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
ACLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.05 | +80% |
| Q3 2026 | $3.37 | -20% |
| Q2 2026 | $2.99 | -39% |
| Q1 2026 | $3.22 | -41% |
| Q4 2025 | $3.80 | -38% |
| Q3 2025 | $4.23 | -37% |
| Q2 2025 | $4.89 | -33% |
| Q1 2025 | $5.46 | -28% |
| Q4 2024 | $6.15 | -17% |
ACLS's earnings per share have fallen from their peak: $3.37 over the past year, against $7.57 in early 2024.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over ACLS in the latest year-over-year earnings comparison.
ACLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $237.8M | +11% |
| Q2 2026 | $215.2M | +11% |
| Q1 2026 | $199M | +3.3% |
| Q4 2025 | $238.3M | -5.6% |
| Q3 2025 | $213.6M | -17% |
| Q2 2025 | $194.5M | -24% |
| Q1 2025 | $192.6M | -24% |
| Q4 2024 | $252.4M | -19% |
ACLS's revenue is recovering but still below its 2023 peak: $238M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -0.2 points |
| Q2 2026 | 9.4% | -5.5 points |
| Q1 2026 | 4% | -11 points |
| Q4 2025 | 15% | -6.4 points |
| Q3 2025 | 12% | -6.6 points |
| Q2 2025 | 15% | -5.7 points |
| Q1 2025 | 15% | -7.3 points |
| Q4 2024 | 22% | -3.9 points |
ACLS's operating margin was 12% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over ACLS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over ACLS on profitability, with a higher operating margin.
ACLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $37.7M | -13% |
| Q2 2026 | $14.8M | -61% |
| Q1 2026 | $16.3M | -53% |
| Q4 2025 | -$8.9M | -210% |
| Q3 2025 | $43.3M | +3.6% |
| Q2 2025 | $37.7M | -0.8% |
| Q1 2025 | $34.8M | -14% |
| Q4 2024 | $8.1M | -85% |
ACLS still generates free cash flow, though less than at its 2022 peak: $60M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over ACLS on cash flow, with more consistent year-over-year improvement.
ACLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -29K shares |
| 1 year | -1.1% | -345K shares |
| 3 years | -6.2% | -2.1M shares |
| 5 years | -8.8% | -3M shares |
| Available history | -8% | -2.7M shares |
ACLS has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $25.2M |
| Q3 2025 | $32.3M |
| Q2 2025 | $45.3M |
| Q1 2025 | $18.2M |
| Q4 2024 | $15.1M |
| Q3 2024 | $15.4M |
| Q2 2024 | $15M |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ACLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
ACLS has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
ACLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 23.9 | Neutral |
ACLS's weekly RSI is 44 (neutral) and its Stochastic is 24 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
ACLS PE vs Technology Sector
| Metric | ACLS | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 28x | 15% above |
| PE % | 82 | 35 | 47 pts above |
ACLS is trading at 32x earnings, a 15% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over ACLS on valuation relative to its sector.
ACLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $116.0 | 6.8% below |
| 20 week MA | $123.9 | 13% below |
| 50 week MA | $117.7 | 8.2% below |
| 100 week MA | $93.6 | 15% above |
| 200 week MA | $110.6 | 2.3% below |
ACLS has stronger trend alignment. ACLS is above 1 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
ACLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.2 | $29.2 | +21% |
| 2021 | $29.2 | $68.1 | +133% |
| 2022 | $68.1 | $80.3 | +18% |
| 2023 | $80.3 | $129.7 | +62% |
| 2024 | $129.7 | $71.2 | -45% |
| 2025 | $71.2 | $82.6 | +16% |
| 2026 YTD | $82.6 | $108.1 | +31% |
ACLS's yearly returns have swung widely, from +133% in 2021 to −45% in 2024. It's up 31% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over ACLS on returns for 2026, with the stronger performance.